← Evidence map

ArticleKidney international reports2026

Efficacy and Safety of Telitacicept in Posttransplant Recurrent IgA Nephropathy.

Mingxing Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42064224